Corvus Pharmaceuticals, Inc.

CRVS · Nasdaq · SIC 2834: Pharmaceutical Preparations
189
SEC Filings

Business Summary

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapy treatments. Its pipeline includes soquelitinib (formerly CPI-818), ciforadenant, and mupadolimab. The company conducts clinical trials for these product candidates, leverages biomarker data to support clinical development, and has a collaboration with Angel Pharmaceuticals. Corvus has not yet commercialized any products.

Next Earnings

Q2 FY2026 — expected 2026-08-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCRVSdiscussed_in_filing Cybersecurity
topic_mentionCRVSdiscussed_in_filing Trusted Computing
topic_mentionCRVSdiscussed_in_filing Blockchain & Crypto
topic_mentionCRVSdiscussed_in_filing Regulation
topic_mentionCRVSdiscussed_in_filing Healthcare & Bio
topic_mentionCRVSdiscussed_in_filing Platform & Ecosystem
topic_mentionCRVSdiscussed_in_filing Sovereign & Government
topic_mentionCRVSdiscussed_in_filing Cybersecurity
topic_mentionCRVSdiscussed_in_filing Trusted Computing
topic_mentionCRVSdiscussed_in_filing Blockchain & Crypto
topic_mentionCRVSdiscussed_in_filing Regulation
topic_mentionCRVSdiscussed_in_filing Healthcare & Bio
topic_mentionCRVSdiscussed_in_filing Platform & Ecosystem
topic_mentionCRVSdiscussed_in_filing Sovereign & Government
topic_mentionCRVSdiscussed_in_filing Cybersecurity
topic_mentionCRVSdiscussed_in_filing Trusted Computing
topic_mentionCRVSdiscussed_in_filing Blockchain & Crypto
topic_mentionCRVSdiscussed_in_filing Regulation
topic_mentionCRVSdiscussed_in_filing Healthcare & Bio
topic_mentionCRVSdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001104659-26-027047EDGAR80K words
2025-03-252024-12-310001558370-25-003621EDGAR—
2024-03-192023-12-310001558370-24-003567EDGAR—
2023-03-282022-12-310001558370-23-004792EDGAR—
2022-03-102021-12-310001558370-22-003281EDGAR—
2021-03-252020-12-310001558370-21-003462EDGAR—
2020-03-092019-12-310001558370-20-002232EDGAR—
2019-03-072018-12-310001558370-19-001660EDGAR—
2018-03-012017-12-310001047469-18-001209EDGAR—
2017-03-102016-12-310001047469-17-001459EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001104659-25-106259EDGAR56K words
2025-08-072025-06-300001558370-25-010755EDGAR—
2025-05-082025-03-310001558370-25-006966EDGAR—
2024-11-122024-09-300001558370-24-015306EDGAR—
2024-08-062024-06-300001558370-24-011076EDGAR—
2024-05-072024-03-310001558370-24-007093EDGAR—
2023-11-072023-09-300001558370-23-017981EDGAR—
2023-08-082023-06-300001558370-23-013914EDGAR—
2023-05-082023-03-310001558370-23-008503EDGAR—
2022-11-032022-09-300001558370-22-016233EDGAR—
2022-08-082022-06-300001558370-22-012619EDGAR—
2022-05-052022-03-310001558370-22-007374EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-130001104659-26-027390EDGAR21K words
2026-03-120001171843-26-001526EDGAR—
2026-01-230001104659-26-005968EDGAR—
2026-01-200001104659-26-005035EDGAR—
2026-01-200001104659-26-004795EDGAR—
2025-11-040001171843-25-006973EDGAR—
2025-10-020001104659-25-096103EDGAR—
2025-08-070001171843-25-005180EDGAR—
2025-06-130001171843-25-003881EDGAR—
2025-06-040001171843-25-003661EDGAR—

189 total filings indexed. 157 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology cancer-immunotherapy

Company Identity

CIK0001626971
TickerCRVS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 71f9d8f77e75c535fc0e5c9eb7d4e07f6b2e9dd9f99d231b62ba72c20a9ee9f1
parent: 0614597fb09f4114f8f83231f92b7196d4b4e7d2d74f49c5025cb81c89f1e6ee
content hash: 1a80cdf4b5fc2e57b0710ad7e22f49769e5d4e7f82d44e629f61118a22b4e7eb
signed: 2026-04-13T04:44:30.611Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf